{
  "trial_id": "NCT02524106",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Evidence of a personally signed and dated informed consent document indicating that the subject (or a legal representative) has been informed of all pertinent aspects of the study.",
      "label": "met"
    },
    {
      "criterion": "Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "History of a cardiovascular or cerebrovascular event or procedure (eg, myocardial infarction, stroke, transient ischemic attack, angioplasty) during the past 90 days.",
      "label": "triggers"
    },
    {
      "criterion": "Congestive heart failure, New York Heart Association functional class IV, or left ventricular ejection fraction measured by imaging known to be <25%.",
      "label": "triggers"
    }
  ],
  "notes": "The patient has type 1 diabetes and cardiomyopathy. He is being treated with ACE inhibitors and Beta blockers.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT02524106",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}